Medications

Common psychiatric drugs appear to reduce effect of COVID-19

A new meta-analysis shows that psychiatric medications can give some protection against COVID-19, with the common antidepressant fluvoxamine showing the strongest effect. Patients taking fluvoxamine showed reduced symptoms, ...

Medications

No significant association found for ADHD meds, CVD risk

There seems to be no statistically significant association between attention-deficit/hyperactivity disorder (ADHD) medications and cardiovascular disease (CVD) risk, according to a systematic review and meta-analysis published ...

Psychology & Psychiatry

Researching depression in low-income women

The importance of addressing depression among low-income women in multiple contexts is a theme of recent research by April Ivey, GRS'22, Professor Jacqueline Corcoran, and others at Penn's School of Social Policy & Practice ...

Psychology & Psychiatry

Actions speak louder than words when it comes to memory

Whether you're old or young, memory can be a challenge for all kinds of reasons, and most of us would welcome strategies to help improve our memory. Waterloo's researchers in psychology have been helping with this area of ...

Neuroscience

Underweight, obesity may increase risk for migraine

Underweight and obesity are associated with increased migraine risk, according to a review published in the July/August issue of Headache: The Journal of Head and Face Pain.

Oncology & Cancer

A powerful new plant-based weapon against cancer

Cancer is caused by abnormal cell proliferation and is one of the main public health issues in the world. Recently, the research group led by Researcher Du Peng of PKU School of Life Sciences discovered that a plant immune ...

page 5 from 8